Motilal Oswal BSE Healthcare ETF - Growth - Regular Plan

Other Plans and Options
  • 0.06 %Nav, as on 22-01-2025

  • Previous Nav

  • Net Change on 22-01-2025

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI -3.39 -1.08 31.21 21.12 25.70 15.88

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Nifty 50 ETF Jul 22, 2015 8.56 10.76 15.02 0.04 192,978.10
SBI BSE SENSEX ETF Mar 15, 2013 8.17 10.28 14.48 0.04 114,572.21
UTI Nifty 50 ETF Sep 01, 2015 8.57 10.77 15.02 0.05 57,902.18
UTI BSE Sensex ETF Sep 01, 2015 8.17 10.28 14.47 0.05 44,121.79
Nippon India ETF Nifty 50 BeES Dec 28, 2001 8.57 10.78 15.05 0.04 36,638.89

Fund Holdings as on 31-December-2024

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddy's Laboratories Limited

  • Max Healthcare Institute Limited

  • Divi's Laboratories Limited

  • Apollo Hospitals Enterprise Limited

  • Lupin Limited

  • Fortis Healthcare Limited

  • Aurobindo Pharma Limited

  • Torrent Pharmaceuticals Limited

  • Alkem Laboratories Limited

  • Mankind Pharma Limited

  • Zydus Lifesciences Limited

  • Glenmark Pharmaceuticals Limited

  • Laurus Labs Limited

  • IPCA Laboratories Limited

  • Biocon Limited

  • Piramal Pharma Limited

  • Syngene International Limited

  • Abbott India Limited

  • Krishna Institute Of Medical Sciences Limited

  • Suven Pharmaceuticals Limited

  • Gland Pharma Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Concord Biotech Limited

  • Ajanta Pharma Limited

  • Natco Pharma Limited

  • Neuland Laboratories Limited

  • Aster DM Healthcare Limited

  • Dr. Lal Path Labs Limited

  • Wockhardt Limited

  • Poly Medicure Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Global Health Limited

  • Granules India Limited

  • Narayana Hrudayalaya Limited

  • Jubilant Pharmova Limited

  • Pfizer Limited

  • Rainbow Childrens Medicare Limited

  • Marksans Pharma Limited

  • Alembic Pharmaceuticals Limited

  • Jupiter Life Line Hospitals Limited

  • Eris Lifesciences Limited

  • Sanofi India Limited

  • Metropolis Healthcare Limited

  • Caplin Point Laboratories Limited

  • Onesource Specialty Pharma Limited

  • Ami Organics Limited

  • Vijaya Diagnostic Centre Limited

  • AstraZeneca Pharma India Limited

  • Strides Pharma Science Limited

  • Shilpa Medicare Limited

  • Procter & Gamble Health Limited

  • Aarti Pharmalabs Limited

  • Glenmark Life Sciences Limited

  • Indegene Limited

  • Kovai Medical Center and Hospital Limited

  • Orchid Pharma Limited

  • Morepen Laboratories Limited

  • FDC Limited

  • Indraprastha Medical Corporation Limited

  • Sequent Scientific Limited

  • Solara Active Pharma Sciences Limited

  • Net Receivables / (Payables)

  • Sun Pharma Advanced Research Company Limited

  • Healthcare Global Enterprises Limited

  • Supriya Lifescience Limited

  • Dishman Carbogen Amcis Limited

  • Innova Captab Limited

  • Advanced Enzyme Technologies Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • Aarti Drugs Limited

  • Krsnaa Diagnostics Limited

  • Unichem Laboratories Limited

  • Hikal Limited

  • Thyrocare Technologies Limited

  • Blue Jet Healthcare Ltd

  • Indoco Remedies Limited

  • Gufic Biosciences Limited

  • Bliss GVS Pharma Limited

  • Gujarat Themis Biosyn Limited

  • RPG Life Sciences Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Syncom Formulations India Limited

  • Hester Biosciences Limited

  • Artemis Medicare Services Limited

  • Sigachi Industries Limited

  • Suven Life Sciences Limited

  • Windlas Biotech Limited

  • Themis Medicare Limited

  • Lincoln Pharmaceuticals Limited

  • Vimta Labs Limited

  • SMS Pharmaceuticals Limited

  • Tarsons Products Limited

  • Shalby Limited

  • Novartis India Limited

  • Kopran Limited

  • GPT Healthcare Limited

  • NGL Fine Chem Limited

  • KMC Speciality Hospitals (India) Limited

  • Sastasundar Ventures Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Chemicals

  • Plastic Products

  • Trading

  • Finance - NBFC

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal BSE Healthcare ETF

Scheme Analysis

Motilal Oswal BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹31.91 crore. Motilal Oswal BSE Healthcare ETF is benchmarked against BSE Health Care - TRI as primary index.

The NAV of Motilal Oswal BSE Healthcare ETF ended up ₹0.03(0.06%)yesterday to ₹42.9391.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022 40548002
amc@motilaloswal.com
022-22816161